Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
8000-42-8
Molecular formula
Not available
Molecular weight
Not available
Drug class
Botanical essential oil (Carum carvi)traditional carminative and gastrointestinal herbal preparation
Mechanism of action
Caraway essential oil contains volatile constituents including carvone and limonene. It is traditionally used for carminative and antispasmodic effects in the gastrointestinal tract; the precise pharmacological contribution of individual constituents is not fully established.
Indications / reported uses
Traditional symptomatic relief of mild gastrointestinal complaints such as bloating and flatulence in authorised herbal medicinal products; use is formulation- and jurisdiction-specific
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Caraway Oil PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Caraway Oil Permitted Daily Exposure (PDE) report (the Caraway Oil PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Caraway Oil Occupational Exposure Limit (OEL) report (the Caraway Oil OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.